ABVX
Price
$88.10
Change
+$2.55 (+2.98%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
6.41B
2 days until earnings call
MDXXF
Price
$0.10
Change
+$0.01 (+11.11%)
Updated
Sep 4 closing price
Capitalization
10.01M
Interact to see
Advertisement

ABVX vs MDXXF

Header iconABVX vs MDXXF Comparison
Open Charts ABVX vs MDXXFBanner chart's image
Abivax SA
Price$88.10
Change+$2.55 (+2.98%)
Volume$38.61K
Capitalization6.41B
PharmAla Biotech Holdings
Price$0.10
Change+$0.01 (+11.11%)
Volume$92.4K
Capitalization10.01M
ABVX vs MDXXF Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. MDXXF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and MDXXF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ABVX: $85.55 vs. MDXXF: $0.10)
Brand notoriety: ABVX and MDXXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 45% vs. MDXXF: 336%
Market capitalization -- ABVX: $6.29B vs. MDXXF: $10.01M
ABVX [@Biotechnology] is valued at $6.29B. MDXXF’s [@Biotechnology] market capitalization is $10.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileMDXXF’s FA Score has 0 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • MDXXF’s FA Score: 0 green, 5 red.
According to our system of comparison, MDXXF is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while MDXXF’s TA Score has 6 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 4 bearish.
  • MDXXF’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MDXXF is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а +4.79% price change this week, while MDXXF (@Biotechnology) price change was +15.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

ABVX is expected to report earnings on Sep 08, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($6.42B) has a higher market cap than MDXXF($10M). ABVX YTD gains are higher at: 1068.716 vs. MDXXF (-39.769). MDXXF has higher annual earnings (EBITDA): -1.86M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. MDXXF (1.25M). MDXXF has higher revenues than ABVX: MDXXF (421K) vs ABVX (0).
ABVXMDXXFABVX / MDXXF
Capitalization6.42B10M64,150%
EBITDA-170.04M-1.86M9,156%
Gain YTD1068.716-39.769-2,687%
P/E RatioN/AN/A-
Revenue0421K-
Total Cash104M1.25M8,353%
Total Debt92.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABVXMDXXF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASVIX10.550.15
+1.44%
American Century Small Cap Value Inv
NBMIX51.060.65
+1.29%
Neuberger Berman Small Cap Growth Inv
BMDIX23.150.24
+1.05%
Baird Mid Cap Growth Institutional
PXIIX22.570.21
+0.94%
Virtus KAR Equity Income I
VDIPX29.510.21
+0.72%
Vanguard Developed Markets Index Ins Pls

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+2.27%
IMNN - ABVX
57%
Loosely correlated
-0.17%
CLSD - ABVX
51%
Loosely correlated
+3.00%
ANEB - ABVX
46%
Loosely correlated
-2.85%
MLTX - ABVX
38%
Loosely correlated
+0.37%
XENE - ABVX
38%
Loosely correlated
-0.49%
More

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
+11.76%
NICXF - MDXXF
45%
Loosely correlated
N/A
ZIVO - MDXXF
22%
Poorly correlated
-11.76%
NGNE - MDXXF
20%
Poorly correlated
-1.31%
TRML - MDXXF
13%
Poorly correlated
-0.04%
ABVX - MDXXF
12%
Poorly correlated
+2.27%
More